The sale represented 5.85% of direct holdings, reducing direct ownership to 98,282 shares (0.2122% of shares outstanding).

Wells Fargo raised the firm’s price target on Omnicell (OMCL) to $52 from $43 and keeps an Overweight rating on the shares. The firm added ...

Omnicell, Inc. OMCL, a major provider of medication, supply management solutions and adherence tools to healthcare systems and pharmacies, recently inked a deal to buy pharmacy-based patient care ...

Omnicell, Inc. OMCL has witnessed strong momentum in the past year. Shares of the company have risen 41.6% against a 11.3% decline of the industry during the same time frame. The S&P 500 composite has ...

Automating the future of patient care. That's Omnicell's goal for its new Innovation Lab, which is opening in Austin next week. Michael Garel, senior director of innovation at Omnicell, told the ...

MOUNTAIN VIEW, Calif., Oct. 18, 2012 /PRNewswire/ -- Omnicell, Inc. (Nasdaq: OMCL) and Cerner (Nasdaq: CERN) today announced the formation of an agreement focused on interoperability between Cerner® ...

Mercyhealth has chosen to implement Omnicell‘s XR2 Automated Central Pharmacy System in an effort to increase its pharmacy’s efficiency and improve patient safety. The technology will be adopted at ...

Omnicell reported that some of its information technology systems were affected by ransomware. On May 4, Omnicell, a provider of medication management and adherence tools for health systems and ...

Omnicell is growing its portfolio of medication management solutions and adherence tools. The Mountain View, Calif.-based company has entered into a definitive agreement with pharmacy software ...

Omnicell (NASDAQ:OMCL) priced $150 million principal amount of 1.00% convertible senior notes due 2029, with an option to buy an additional $22.5 million for underwriters. Omnicell plans to raise $144 ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Omnicell ( (OMCL) ) has shared an update.

After a solid 2x rise since March lows of this year, at the current price of around $115 per share, Omnicell stock (NASDAQ: OMCL), a medication management services provider, has reached its near term ...